Additional benefit of lamivudine treatment as a preventive therapy for hepatic encephalopathy in patients with decompensated liver cirrhosis associated with hepatitis B.

International journal of molecular medicine

Volumn 10, Issue 5, 2002, Pages 647-648

  Hanada, Shinichiro ^a   Kumashiro, Ryukichi ^a   Kaji, Ryohei ^a   Harada, Masaru ^a   Sata, Michio ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; LAMIVUDINE;

ARTICLE; CASE REPORT; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMAN; LIVER CIRRHOSIS; MIDDLE AGED; RECURRENT DISEASE;

ANTIVIRAL AGENTS; FEMALE; HEPATIC ENCEPHALOPATHY; HEPATITIS B; HUMANS; LAMIVUDINE; LIVER CIRRHOSIS; MIDDLE AGED; RECURRENCE;

EID: 0036835386     PISSN: 11073756     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)